http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1831218

Outgoing Links

Predicate Object
contentType Journal Article|Comment
endingPage 642
issn 1875-8908
1387-2877
issueIdentifier 2
pageRange 641-642
publicationName Journal of Alzheimer's disease : JAD
startingPage 641
bibliographicCitation Mattace-Raso F. Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer's disease? J Alzheimers Dis. 2014;41(2):641–2. doi: 10.3233/jad-140016. PMID: 24748117.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0942a120f48cb628b4a6a3f09cc9f552
date 2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3233/jad-140016
https://pubmed.ncbi.nlm.nih.gov/24748117
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
https://portal.issn.org/resource/ISSN/1875-8908
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Is Memantine + Acetylcholinesterase Inhibitor Treatment Superior to Either Therapy Alone in Alzheimer's Disease?
discusses http://id.nlm.nih.gov/mesh/M0004295
http://id.nlm.nih.gov/mesh/M0013333
http://id.nlm.nih.gov/mesh/M0028009
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544Q000188
http://id.nlm.nih.gov/mesh/D002800Q000008
http://id.nlm.nih.gov/mesh/D008559Q000008
http://id.nlm.nih.gov/mesh/D018697Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_971f5dc4b6d2e06a073200edd8457eb6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404

Total number of triples: 34.